US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
JPH07501547A
(ja)
*
|
1991-11-26 |
1995-02-16 |
セプラコア,インコーポレーテッド |
光学的に純粋な(−)アムロジピンを用いる,高血圧,狭心症および他の疾患を治療するための方法および組成物
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
AT399718B
(de)
*
|
1992-04-16 |
1995-07-25 |
Lek Tovarna Farmacevtskih |
Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
USRE39384E1
(en)
|
1993-09-01 |
2006-11-07 |
Smithkline Beecham P.L.C. |
Substituted thiazolidinedione derivatives
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
CA2215234C
(fr)
|
1995-03-16 |
2001-12-11 |
Pfizer Inc. |
Composition renfermant de l'amlopidine ou un sel, ou de la felodipine et un inhibiteur de l'enzyme de conversion de l'angiotensine
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
WO1999018957A1
(fr)
*
|
1998-03-26 |
1999-04-22 |
Reddy-Cheminor, Inc. |
Composition pharmaceutique stable contenant du besylate d'anilodipine et de l'atenolol
|
PL189666B1
(pl)
*
|
1998-04-09 |
2005-09-30 |
Adamed Sp Z Oo |
Sposób otrzymywania benzenosulfonianu amlodypiny
|
RU2450813C2
(ru)
|
1998-07-10 |
2012-05-20 |
Новартис Аг |
Гипотензивная комбинация валсартана и блокатора кальциевых каналов
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
US20070072828A1
(en)
*
|
1998-07-24 |
2007-03-29 |
Yoo Seo H |
Bile preparations for colorectal disorders
|
US7129265B2
(en)
*
|
1999-04-23 |
2006-10-31 |
Mason R Preston |
Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
|
EP1180102B9
(fr)
|
1999-05-27 |
2005-03-02 |
Pfizer Products Inc. |
Promedicaments communs d'amlodipine et d'atorvastatine
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
UA72768C2
(en)
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
US6835742B2
(en)
|
2000-08-04 |
2004-12-28 |
R. Preston Mason |
Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
CA2433193C
(fr)
|
2000-12-29 |
2006-01-31 |
Pfizer Limited |
Derive d'amide d'amlodipine
|
DE60116514T2
(de)
|
2000-12-29 |
2006-08-17 |
Pfizer Ltd., Sandwich |
Amlodipinhemimaleat
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
CA2433284A1
(fr)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Standards de reference destines a la determination de la purete ou de la stabilite de maleate d'amlodipine et procedes correspondants
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
EP1309556B1
(fr)
|
2000-12-29 |
2004-11-24 |
Pfizer Limited |
Fumarate d'amlodipine
|
AP2003002820A0
(en)
*
|
2000-12-29 |
2003-06-30 |
Pfizer Ltd |
"Process for making amlodipine maleate"
|
WO2002053540A1
(fr)
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Derive aspartate de l'amlodipine utilise comme antagoniste des canaux calciques
|
US6653481B2
(en)
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
DK1221438T3
(da)
*
|
2001-01-09 |
2007-06-18 |
Siegfried Generics Int Ag |
Salte af Amlodipinmesylat
|
GB0103046D0
(en)
|
2001-02-07 |
2001-03-21 |
Novartis Ag |
Organic Compounds
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
US20030027848A1
(en)
*
|
2001-06-15 |
2003-02-06 |
Anne Billotte |
Stabilized formulations
|
WO2003004025A1
(fr)
*
|
2001-07-06 |
2003-01-16 |
Lek Pharmaceutical And Chemical Company D.D. |
Benzenesulfonate d'amlodipine de haute purete et procede de preparation correspondant
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
AR037565A1
(es)
*
|
2001-11-21 |
2004-11-17 |
Synthon Bv |
Formas de sales de amlodipina y procedimientos para prepararlas.
|
HU226642B1
(en)
*
|
2001-12-17 |
2009-05-28 |
Egis Gyogyszergyar Nyilvanosan |
Amlodipine bezylate tablets having extended stability and process for producing the same
|
NL1019882C2
(nl)
*
|
2002-02-01 |
2003-08-04 |
Synthon Licensing |
Amlodipine vrije base.
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
WO2003089414A1
(fr)
*
|
2002-04-13 |
2003-10-30 |
Hanlim Pharmaceutical Co., Ltd. |
Nicotinate d'amlodipine et son procede de preparation
|
EP1501551B1
(fr)
|
2002-05-06 |
2009-11-18 |
Endocyte, Inc. |
Agents d'imagerie cibles pas le récepteur de la folate
|
EG24716A
(en)
|
2002-05-17 |
2010-06-07 |
Novartis Ag |
Combination of organic compounds
|
SI21233A
(sl)
*
|
2002-05-31 |
2003-12-31 |
LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. |
Kristalni hidratni obliki amlodipin benzensulfonata visoke čistote, postopki za njuno pripravo in uporaba
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
KR100538641B1
(ko)
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100462304B1
(ko)
*
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100496436B1
(ko)
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100467669B1
(ko)
*
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
MXPA05002253A
(es)
|
2002-08-29 |
2005-06-08 |
Taisho Pharma Co Ltd |
Sales bencenosulfonato de derivados de 4-fluoro-2-cianopirrolidina.
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
AU2003260984A1
(en)
|
2002-09-11 |
2004-04-30 |
Hanlim Pharmaceutical Co., Ltd. |
S-(-)-amlodipine nicotinate and process for the preparation thereof
|
WO2004026834A1
(fr)
*
|
2002-09-19 |
2004-04-01 |
Cj Corporation |
Sel acide organique cristallin d'amlodipine
|
US7166641B2
(en)
*
|
2002-10-02 |
2007-01-23 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
|
EP1407773A1
(fr)
*
|
2002-10-08 |
2004-04-14 |
Council of Scientific and Industrial Research |
Procede pour la preparation des sels de s(-)amlodipine
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
AU2002368531A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
MXPA05007876A
(es)
|
2003-01-27 |
2005-09-21 |
Hanmi Pharm Ind Co Ltd |
Camsilato de amlodipino amorfo, estable, proceso para preparar el mismo y composicion para la administracion oral del mismo.
|
EA009983B1
(ru)
*
|
2003-01-31 |
2008-04-28 |
Дайити Санкио Компани, Лимитед |
Лекарственное средство для профилактики и лечения артериосклероза и гипертензии
|
KR20040072363A
(ko)
*
|
2003-02-12 |
2004-08-18 |
주식회사 대웅 |
신규한 암로디핀 사이클라메이트 염 및 그의 제조방법
|
US20060270715A1
(en)
*
|
2003-02-28 |
2006-11-30 |
Singh Romi B |
Dosage forms of amlodipine and processes for their preparation
|
EP2865681A3
(fr)
|
2003-04-25 |
2015-08-19 |
Cadila Healthcare Limited |
Sels de clopidogrel besylate et processus de préparation
|
DE112004000712T5
(de)
*
|
2003-04-25 |
2006-10-19 |
Cipla Ltd. |
Verfahren zur Herstellung von Amlodipinmesilat-Monohydrat
|
WO2004103959A2
(fr)
*
|
2003-05-16 |
2004-12-02 |
Ambit Biosciences Corporation |
Composés hétérocycliques et utilisations
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
EP1658283A2
(fr)
|
2003-05-30 |
2006-05-24 |
Ranbaxy Laboratories, Ltd. |
Derives substitues du pyrrole et leur utilisation comme inhibiteurs de hmg-co
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
US20050048118A1
(en)
*
|
2003-07-25 |
2005-03-03 |
Joan Cucala Escoi |
Modified release venlafaxine hydrochloride tablets
|
WO2005042485A1
(fr)
*
|
2003-10-30 |
2005-05-12 |
Sk Chemicals, Co., Ltd. |
Sels d'addition acide d'amlodipine
|
KR100841409B1
(ko)
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
US20060035940A1
(en)
*
|
2004-03-16 |
2006-02-16 |
Sepracor Inc. |
(S)-Amlodipine malate
|
EP1750862B1
(fr)
|
2004-06-04 |
2011-01-05 |
Teva Pharmaceutical Industries Ltd. |
Composition pharmaceutique contenant de l'irbesartan
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
US8173627B2
(en)
*
|
2004-08-30 |
2012-05-08 |
Seo Hong Yoo |
Neuroprotective effect of solubilized UDCA in focal ischemic model
|
AU2005295541B2
(en)
*
|
2004-10-15 |
2011-02-17 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
WO2006050165A2
(fr)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Procedes et compositions de reduction de la neurodegeneration dans la sclerose laterale amyotrophique
|
ES2328384T3
(es)
*
|
2004-11-23 |
2009-11-12 |
Warner-Lambert Company Llc |
Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
|
WO2006059217A1
(fr)
*
|
2004-12-01 |
2006-06-08 |
Ranbaxy Laboratories Limited |
Formes posologiques solides stables d'amlodipine bezylate, et procedes d'elaboration correspondants
|
WO2006070248A1
(fr)
*
|
2004-12-28 |
2006-07-06 |
Ranbaxy Laboratories Limited |
Procedes permettant de preparer des formes posologiques pharmaceutiques solides et stables a base d'atorvastatine et d'amlodipine
|
US20080268049A1
(en)
*
|
2005-02-11 |
2008-10-30 |
Dhaliwal Mona |
Stable Solid Dosage Forms of Amlodipine and Benazepril
|
WO2006131923A2
(fr)
*
|
2005-06-07 |
2006-12-14 |
Ramot At Tel Aviv University Ltd. |
Nouveaux sels de medicaments psychotropes conjugues et leurs procedes de preparation
|
WO2007001066A1
(fr)
*
|
2005-06-27 |
2007-01-04 |
Daiichi Sankyo Company, Limited |
Préparation pharmaceutique contenant un antagoniste du récepteur de l'angiotensine ii et un bloqueur du canal calcique
|
EP1797885B1
(fr)
*
|
2005-09-28 |
2008-03-26 |
Teva Pharmaceutical Industries Ltd. |
Combinations stables d'amlodipine besylate et de benazeprile hydrochloride
|
US8158146B2
(en)
|
2005-09-28 |
2012-04-17 |
Teva Pharmaceutical Industries Ltd. |
Stable combinations of amlodipine besylate and benazepril hydrochloride
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
BRPI0618379A2
(pt)
|
2005-11-08 |
2011-08-30 |
Ranbaxy Lab Ltd |
processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
FR2894826B1
(fr)
*
|
2005-12-21 |
2010-10-22 |
Servier Lab |
Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
|
AU2007274583B2
(en)
|
2006-07-17 |
2012-11-01 |
Bar-Ilan University |
Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
|
KR100795313B1
(ko)
|
2006-09-05 |
2008-01-21 |
현대약품 주식회사 |
암로디핀 베실레이트를 포함하는 약학 조성물
|
TWI399223B
(zh)
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
CN101663262B
(zh)
|
2006-12-01 |
2014-03-26 |
百时美施贵宝公司 |
用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
|
JP2011502953A
(ja)
*
|
2006-12-21 |
2011-01-27 |
ゼノポート,インコーポレーテッド |
ジメチル置換されたレボドパジエステルのプロドラッグ、組成物及び使用方法
|
US8058312B2
(en)
|
2007-01-29 |
2011-11-15 |
Hanall Biopharma Co., Ltd. |
N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
WO2008124121A1
(fr)
*
|
2007-04-06 |
2008-10-16 |
Scidose, Llc |
Polythérapie associant des statines et des 1,4-dihydropyridine-3,5-dicarboxydiesters et combinaisons de ceux-ci
|
US8748648B2
(en)
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
US8143314B1
(en)
*
|
2007-09-13 |
2012-03-27 |
Robert Carl Stover |
Methods and formulations for treating ineffective or decreased esophageal motility
|
EP2203418B1
(fr)
*
|
2007-09-21 |
2017-10-25 |
HanAll Biopharma Co., Ltd. |
Diamide dicarboxylate n, n- diméthyl imidodicarbonimidique, son procédé de production et compositions pharmaceutiques le comprenant
|
AU2008344891A1
(en)
|
2007-12-31 |
2009-07-09 |
Lupin Limited |
Pharmaceutical compositions of amlodipine and valsartan
|
US8207369B2
(en)
|
2008-02-11 |
2012-06-26 |
Ramot At Tel-Aviv University Ltd. |
Conjugates for treating neurodegenerative diseases and disorders
|
CN101564536B
(zh)
*
|
2008-04-21 |
2010-12-15 |
鲁南制药集团股份有限公司 |
一种治疗高血压的药物组合物缓控释制剂
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
DK2361248T3
(en)
|
2008-06-27 |
2019-01-14 |
Celgene Car Llc |
Heteroberl compounds and uses thereof
|
US9290445B2
(en)
*
|
2008-10-20 |
2016-03-22 |
Xenoport, Inc. |
Methods of synthesizing a levodopa ester prodrug
|
US8399513B2
(en)
*
|
2008-10-20 |
2013-03-19 |
Xenoport, Inc. |
Levodopa prodrug mesylate hydrate
|
US20110294860A1
(en)
*
|
2008-12-17 |
2011-12-01 |
Medrx Co., Ltd. |
Aqueous oral preparation of stable amlodipine
|
CA2749903C
(fr)
|
2009-01-23 |
2016-09-06 |
Jae Hyun Park |
Composition pharmaceutique solide comprenant de l'amlodipine et du losartan et son procede de fabrication
|
JP2013520521A
(ja)
*
|
2009-11-09 |
2013-06-06 |
ゼノポート,インコーポレーテッド |
レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法
|
CA2782514A1
(fr)
|
2009-12-09 |
2011-06-16 |
Biolinerx Ltd. |
Procedes d'amelioration des fonctions cognitives
|
KR20120127495A
(ko)
|
2010-02-12 |
2012-11-21 |
화이자 인코포레이티드 |
8-플루오로-2-{4-[(메틸아미노)메틸]페닐}-1,3,4,5-테트라하이드로-6h-아제피노[5,4,3-cd]인돌-6-온의 염 및 다형체
|
CA2789654A1
(fr)
|
2010-02-24 |
2011-09-01 |
Ramot At Tel-Aviv University Ltd. |
Formes cristallines du sel de trimesylate de perphenazine-gaba et procede de production associe
|
WO2011117876A1
(fr)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
Procédé amélioré pour la préparation de base libre d'amlodipine et des sels d'addition d'acide de celle-ci
|
IT1400309B1
(it)
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
EP2425859A1
(fr)
|
2010-08-08 |
2012-03-07 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Formulations de l'olmesartane
|
EP3144298A1
(fr)
*
|
2010-08-10 |
2017-03-22 |
Celgene Avilomics Research, Inc. |
Sel bésylate d'un inhibiteur btk
|
US8916610B2
(en)
|
2010-09-22 |
2014-12-23 |
Ramot At Tel-Aviv University Ltd. |
Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
|
JP5956999B2
(ja)
|
2010-11-01 |
2016-07-27 |
セルジーン アヴィロミクス リサーチ, インコーポレイテッド |
ヘテロアリール化合物およびその使用
|
MX2013004894A
(es)
|
2010-11-01 |
2013-10-17 |
Celgene Avilomics Res Inc |
Compuestos heterociclicos y usos de los mismos.
|
US8796255B2
(en)
|
2010-11-10 |
2014-08-05 |
Celgene Avilomics Research, Inc |
Mutant-selective EGFR inhibitors and uses thereof
|
WO2012071524A1
(fr)
*
|
2010-11-24 |
2012-05-31 |
Ratiopharm Gmbh |
Sels d'arylsulfonates de fingolimod et leurs procédés de préparation
|
AR088570A1
(es)
|
2011-10-28 |
2014-06-18 |
Celgene Avilomics Res Inc |
Metodos para tratar una enfermedad o trastorno relacionado con la tirosina quinasa de bruton
|
JP6317319B2
(ja)
|
2012-03-15 |
2018-04-25 |
セルジーン シーエーアール エルエルシー |
上皮成長因子受容体キナーゼ阻害剤の固体形態
|
MX356179B
(es)
|
2012-03-15 |
2018-05-17 |
Celgene Avilomics Res Inc |
Sales de un inhibidor de cinasa del receptor del factor de crecimiento epidermico.
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
EP2935226A4
(fr)
|
2012-12-21 |
2016-11-02 |
Celgene Avilomics Res Inc |
Composés hétéroarylés et leurs utilisations
|
US20150374713A1
(en)
|
2013-02-08 |
2015-12-31 |
Wockhardt Limited |
Stable pharmeceutical composition of amlodipine and benazepril or salts thereof
|
CN105188371A
(zh)
|
2013-02-08 |
2015-12-23 |
西建阿维拉米斯研究公司 |
Erk抑制剂及其用途
|
SG11201507496UA
(en)
|
2013-04-17 |
2015-11-27 |
Pfizer |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
ES2741785T3
(es)
|
2014-08-13 |
2020-02-12 |
Celgene Car Llc |
Formas y composiciones de un inhibidor de ERK
|
WO2016055901A1
(fr)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Composés d'amide substitué
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
CN104523588A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-硬脂酸离子液体及其制备方法和用途
|
CN104610130A
(zh)
*
|
2015-01-22 |
2015-05-13 |
华东理工常熟研究院有限公司 |
氨氯地平-棕榈酸离子液体及其制备方法和用途
|
WO2017030893A1
(fr)
|
2015-08-14 |
2017-02-23 |
Endocyte, Inc. |
Méthode d'imagerie utilisant un composé chélateur
|
US20180303811A1
(en)
|
2015-10-23 |
2018-10-25 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
CN105395495A
(zh)
*
|
2015-11-30 |
2016-03-16 |
宜昌东阳光长江药业股份有限公司 |
一种含有苯磺酸氨氯地平的组合物及其制备方法
|
EP3219309A1
(fr)
|
2016-03-17 |
2017-09-20 |
K.H.S. Pharma Holding GmbH |
Compositions pharmaceutiques comprenant combinaisons à dose fixe de amlodipine, de candesartan cilexetil et de hydrochlorothiazide pour le traitement de l'hypertension
|
US20200316029A1
(en)
|
2016-05-30 |
2020-10-08 |
Boehringer Ingelheim International Gmbh |
Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
|
WO2018067959A1
(fr)
|
2016-10-07 |
2018-04-12 |
Silvergate Pharmaceuticals, Inc. |
Formulations d'amlodipine
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
EP3501502A1
(fr)
|
2017-12-20 |
2019-06-26 |
Midas Pharma GmbH |
Compositions pharmaceutiques dosées fixes comprenant de l'amlodipine, du ramipril et de l'atorvastatine
|
WO2019200143A1
(fr)
|
2018-04-11 |
2019-10-17 |
Silvergate Pharmaceuticals, Inc. |
Formulations d'amlodipine
|
CN112955965B
(zh)
|
2018-06-14 |
2024-04-09 |
阿斯利康(英国)有限公司 |
使用二氢吡啶类钙通道阻断剂医药组合物降低血压的方法
|
AU2020209215B2
(en)
|
2019-01-18 |
2023-02-02 |
Astrazeneca Ab |
PCSK9 inhibitors and methods of use thereof
|
US11253474B1
(en)
|
2021-02-01 |
2022-02-22 |
Liqmeds Worldwide Limited |
Pharmaceutical solution of amlodipine
|
EP4052695A1
(fr)
|
2021-03-05 |
2022-09-07 |
Midas Pharma GmbH |
Compositions pharmaceutiques orales stables à libération immédiate à dose fixe comprenant de l'amlodipine, de l'atorvastatine et du candésartan cilexétil
|
WO2023285646A1
(fr)
|
2021-07-15 |
2023-01-19 |
Adamed Pharma S.A |
Composition pharmaceutique comprenant de l'amlodipine, du candésartan cilexetil et de l'hydrochlorothiazide pour le traitement de l'hypertension
|